This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Absolute Antibody
product type :
antibody
product name :
Anti-CD200R [OX-110]
catalog :
Ab00577-7.1
quantity :
200 μg
clonality :
monoclonal
host :
rat
conjugate :
nonconjugated
clone name :
OX-110
The same clone is also sold as:
The same clone is also sold as:
- Invitrogen: MA5-17984, 46-5201-82, MA5-17985, MA5-17982, MA5-17983, 12-5201-82, 12-5201-80, MA1-82713, MA1-82801, 17-5201-82
- OriGene: SM2095PS, SM2095LE, SM2095P, SM2095FX, SM2095FT, SM2095RT, SM2095R, SM2095F
- Bio-Rad: MCA2281A647, MCA2281GA, MCA2281PE
- BioLegend: 123908, 123921, 123917, 123919, 123915, 123916, 123910, 123902, 123913, 123907, 123909, 123918
reactivity :
mouse
application :
flow cytometry
product information
Product Name :
Anti-CD200R [OX-110]
Catalog Number :
Ab00577-7.1
Target :
CD200R
Antibody Species :
Rat
Isotype :
IgG2a
LCFormat :
kappa
Target Synonyms :
OX2R; Cell surface glycoprotein CD200 receptor; cell surface glycoprotein CD 200 receptor; CD200 receptor; CD 200 receptor; CD200cell surface glucoprotein receptor; CD 200 cell surface glycoprotein receptor; cell surface glycoprotein OX2 receptor; OX110; MRC OX
Display Amount :
200 μg
PriceGBP :
285
PriceEUR :
315
Product Type :
Primary Antibody
Clonality :
Monoclonal
ApplicationCodesClone :
FC
Immunogen :
OX-110 was generated from rats using immunogenic mouse fusion protein mCD200RCD4d34.
MarketingCategories :
immunology; adaptive immunity; arthritis; allograph rejection; inflammation
Available Custom Conjugation Options :
AP, HRP, Fluorescein, APC, PE, Biotin Type A, Biotin Type B, Streptavidin, FluoroProbes 647H, Atto488, APC/Cy7, PE/Cy7
UniprotAccessionNo :
Q9ES57
Product Description :
This is a recombinant monoclonal antibody.
company information
Absolute Antibody
Wilton Centre
Redcar
Cleveland
TS10 4RF
Redcar
Cleveland
TS10 4RF
info@absoluteantibody.com
https://absoluteantibody.com/1-617-377-4057
headquarters: United Kingdom
questions and comments